Browsing All Christie Publications by Authors
Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS).Tabernero, J; Shitara, K; Dvorkin, M; Mansoor, Was; Arkenau, H; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; et al. (2018-06)
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial.Shitara, K; Doi, T; Dvorkin, M; Mansoor, Was; Arkenau, H; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; et al. (2018)Trifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of pretreated patients with advanced gastric cancer done in Japan. We investigated whether the treatment was efficacious compared with placebo in a global population.